Nephrology Dialysis Transplantation
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
MO048: Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases.
37.
2022
-
Addressing feasibility challenges to delivering intradialytic exercise interventions: a theory-informed qualitative study.
37:558-574.
2022
-
Phosphate and bone fracture risk in chronic kidney disease patients.
36:405-412.
2021
-
The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.
35:782-789.
2020
-
Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.
35:657-668.
2020
-
Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.
35:283-291.
2020
-
Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease.
34:1453-1460.
2019
-
Con: Vascular access surveillance in mature fistulas: is it worthwhile?.
34:1106-1111.
2019
-
Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study.
34:1145-1154.
2019
-
Nephrology comanagement and the quality of antibiotic prescribing in primary care for patients with chronic kidney disease: a retrospective cross-sectional study.
34:642-649.
2019
-
Incidence of new-onset diabetes mellitus and association with mortality in childhood solid organ transplant recipients: a population-based study.
34:524-531.
2019
-
Risk and complications of venous thromboembolism in dialysis patients.
33:874-880.
2018
-
Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients.
32:1579-1586.
2017
-
When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery.
32:ii23-ii30.
2017
-
Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.
32:gfw076-gfw076.
2017
-
The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.
32:gfw312-gfw312.
2017
-
Con: Meta-analysis: some key limitations and potential solutions.
31:882-885.
2016
-
Opponent's comments.
31:880-881.
2016
-
The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.
31:984-991.
2016
-
Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union.
30:iv76-iv85.
2015
-
Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes.
30:iv26-iv34.
2015
-
Peritoneal dialysis catheter implantation by nephrologists is associated with higher rates of peritoneal dialysis utilization: a population-based study.
30:301-309.
2015
-
Erratum.
29:2152-2152.
2014
-
Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort.
29:1037-1047.
2014
-
High-performance information search filters for acute kidney injury content in PubMed, Ovid Medline and Embase.
29:823-832.
2014
-
Increased bone fractures among elderly United States hemodialysis patients.
29:146-151.
2014
-
Iron toxicity: relevance for dialysis patients..
29:255-259.
2014
-
Living kidney donor estimated glomerular filtration rate and recipient graft survival.
29:188-195.
2014
-
Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.
28:2787-2799.
2013
-
The kidney failure risk equation: on the road to being clinically useful?.
28:1623-1624.
2013
-
Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?.
27:3719-3724.
2012
-
Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.
27:3816-3822.
2012
-
Acute dialysis risk in living kidney donors.
27:3291-3295.
2012
-
Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada.
27:2761-2767.
2012
-
Tests of neuromuscular function are associated with fractures in patients with chronic kidney disease.
27:2384-2388.
2012
-
The authority of next-of-kin in explicit and presumed consent systems for deceased organ donation: an analysis of 54 nations.
27:2533-2546.
2012
-
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
27:1591-1598.
2012
-
Choosing peritoneal dialysis reduces the risk of invasive access interventions.
27:810-816.
2012
-
Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis.
28:182-191.
2012
-
Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials.
26:2316-2322.
2011
-
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case–control study.
26:1888-1894.
2011
-
Troponin levels in hemodialysis patients: interpretation based on guidelines, changing concentrations and high-sensitivity assays.
26:1112-1113.
2011
-
Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial.
25:4002-4009.
2010
-
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial.
25:4009-4017.
2010
-
Creating a model for improved chronic kidney disease care: designing parameters in quality, efficiency and accountability.
25:3623-3630.
2010
-
Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization.
25:2737-2744.
2010
-
Who should be referred for a fistula? A survey of nephrologists.
25:2644-2651.
2010
-
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
25:1639-1646.
2010
-
Is therapy of people with chronic kidney disease ONTARGET?.
25:42-44.
2010
-
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
24:3168-3174.
2009
-
Living kidney donor informed consent practices vary between US and non-US centers.
23:3316-3324.
2008
-
Reply.
23:2429-2430.
2008
-
Environmental prevention of human disease from verocytotoxin-producing Escherichia coli.
23:1819-1822.
2008
-
Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
23:645-653.
2008
-
A well-conducted randomized trial that establishes no benefit of therapy is an important medical advance.
23:52-55.
2008
-
Transplant professionals vary in the long-term medical risks they communicate to potential living kidney donors: an international survey.
22:3040-3045.
2007
-
Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada.
22:2297-2303.
2007
-
Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters.
22:477-483.
2007
-
The direct and indirect economic costs incurred by living kidney donors—a systematic review.
21:1952-1960.
2006
-
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.
21:93-100.
2006
-
Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence.
20:2376-2384.
2005
-
Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis.
20:1617-1622.
2005
-
The growing volume of diabetes-related dialysis: a population based study.
19:3098-3103.
2004
-
Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review.
19:2553-2558.
2004
-
Risk factors for increased variability in dialysis delivery in haemodialysis patients.
18:2112-2117.
2003
-
Reducing vascular access morbidity: a comparative trial of two vascular access monitoring strategies.
18:1174-1180.
2003
-
Comparison of volume of blood processed on haemodialysis adequacy measurement sessions vs regular non-adequacy sessions.
17:1470-1474.
2002
-
Conversion between bromcresol green‐ and bromcresol purple‐measured albumin in renal disease.
16:1925-1929.
2001
-
Tumour‐like calcinosis causing reversible tetraparesis in a patient on continuous ambulatory peritoneal dialysis.
16:622-624.
2001
-
Albumin‐corrected calcium and ionized calcium in stable haemodialysis patients.
15:1841-1846.
2000
-
Implications of the Canada-USA (CANUSA) study of the adequacy of dialysis on peritoneal dialysis schedule.
13:158-163.
1998
-
Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins-a cross-over trial.
13:1452-1457.
1998
-
Assessment of total body water in paediatric patients on dialysis.
11:75-80.
1996
-
Sodium and water profiling in chronic uraemia.
11:38-41.
1996
-
Mesangiocapillary glomerulonephritis associated with ulcerative colitis: case reports of two patients..
10:1923-1924.
1995
-
Clinical impact of biocompatible dialysis membranes on patient morbidity and mortality: an appraisal of the evidence..
10 Suppl 10:52-56.
1995
-
Low incidence of hyperparathyroidism in diabetic renal failure..
21:902-908.
1985
-
Platelet-aggregating immune complexes in idiopathic glomerulonephritis and SLE..
17:621-628.
1980
-
Adaptive design methods in dialysis clinical trials – a systematic review
2021
-
ASSESSING SYMPTOM ASSESSMENT AND MANAGEMENT PROCESSES FOLLOWING THE ADMINISTRATION OF A PATIENT-REPORTED OUTCOME MEASURE TO HEMODIALYSIS PATIENTS IN ONTARIO
2019
-
THE ASSOCIATION BETWEEN INTRA-DIALYTIC SYMPTOM CLUSTERS AND RECOVERY TIME IN PATIENTS UNDERGOING CHRONIC HEMODIALYSIS: AN EXPLORATORY ANALYSIS
2019
-
THE SAFETY AND EFFICACY OF GLUCOCORTICOIDS IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
2019
-
THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS
2017
-
ACUTE CHANGE IN GFR WITH INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM (RASI) AS PREDICTOR OF FUTURE RENAL & CARDIOVASCULAR OUTCOMES
2014
-
NEWER BIOMARKERS IMPROVE PREDICTION OF CARDIOVASCULAR EVENTS IN CKD PATIENTS - CANPREDDICT STUDY OUTCOMES
2014
-
FISTULA PROCEDURE RATES (FPR) AND PRESCRIBED DIALYSIS BLOOD FLOWRATE (BFR): FINDINGS FROM THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)
2013
-
CANADIAN STUDY OF PREDICTION OF DEATH, DIALYSIS AND INTERIM CARDIOVASCULAR EVENTS: CANPREDDICT: BIOMARKERS IMPROVE PREDICTION OF ONE YEAR OUTCOMES IN CHRONIC KIDNEY COHORT
2012
-
Marked variation in the definition and diagnosis of delayed graft function: a systematic review
2008
-
A systematic review and meta-analysis of relapses in AAV: What is the effect of low-dose corticosteroids?
2007
-
Long-term follow-up of relapsing/refractory ANCA associated vasculitis treated with the lymphocyte depleting antibody Alemtuzumab (CAMPATH-1H)
2007
-
Extent of agreement between the registry cause of death and primary cause of death
2005
-
The growing volume of diabetes-related dialysis: a population based study
2004
has subject area
Identity
International Standard Serial Number (ISSN)
-
0071-2736
-
0308-9401
-
0931-0509
Electronic International Standard Serial Number (EISSN)